Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Analgesic Efficacy of Perioperative 9-THC (Namisolin) Patients Undergoing Major Abdominal Surgery: A Randomized, Double Blinded, Placebo-controlled, Parallel Design

Next Previous
Trial Profile

The Analgesic Efficacy of Perioperative 9-THC (Namisolin) Patients Undergoing Major Abdominal Surgery: A Randomized, Double Blinded, Placebo-controlled, Parallel Design

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dronabinol (Primary) ; Diazepam
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms NamiSur

Most Recent Events

  • 03 May 2019 Status changed from recruiting to discontinued.
  • 29 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-005808-17).
  • 11 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top